Ketotifen
Ketotifen is an antihistamine eye treatment used to temporarily relieve itchy eyes caused by allergies — available as eye drops and, in the case of ACUVUE Theravision with Ketotifen, as a daily contact lens that also corrects vision.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 38 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Ketotifen: Patient Information Guide
A plain-language walkthrough of Ketotifen — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Ketotifen is an antihistamine used in the eye to fight allergy-related itch. It's available in several forms across multiple products.
- Alaway, Allergy Eye Drops, Equate Eye Itch Relief, Eye Itch, and other ketotifen ophthalmic drops temporarily relieve itchy eyes due to pollen, ragweed, grass, animal hair, and dander.
- ACUVUE Theravision with Ketotifen — a daily wear, daily disposable drug-eluting contact lens — is specifically indicated to prevent eye itch due to allergic conjunctivitis and to correct refractive ametropia (nearsightedness and farsightedness) in suitable contact lens wearers who do not have red eyes and have no more than 1 diopter of astigmatism.
⚙️How it works▾
Ketotifen blocks H1 histamine receptors in the eye — the targets that trigger allergic itch when you're exposed to allergens like pollen or pet dander. It also stabilizes mast cells (immune cells that release itch-causing chemicals) and helps prevent eosinophils (another type of immune cell) from accumulating in the eye. By acting on both of these pathways, it stops the allergic itch response before it takes hold.
In the ACUVUE Theravision with Ketotifen contact lens, the drug is built into the lens itself and releases gradually while worn on the eye. This allergy-preventing effect has been shown to last through 12 hours in clinical trials.
💊How it's taken▾
How you use ketotifen depends on which product you have.
- Eye drops (Alaway, Allergy Eye Drops, Equate Eye Itch Relief, Eye Itch, and others): Adults and children 3 and older apply 1 drop in the affected eye(s) twice daily, every 8 to 12 hours — no more than twice per day. Children under 3 should see a doctor first. If you use other eye products, wait at least 5 minutes between them.
- ACUVUE Theravision with Ketotifen contact lens: Insert one lens per eye each day. Remove before sleeping and throw it away — it's single-use only. Your eye care professional will set your maximum wearing time. Do not use eye drops or medications containing benzalkonium chloride while wearing these lenses; if you need to apply eye drops, wait at least 10 minutes before inserting the lens.
🤒Side effects — in detail▾
Most people tolerate ketotifen eye products well. The most commonly reported side effects in clinical studies of ACUVUE Theravision with Ketotifen were:
- Eye irritation
- Eye pain
- Irritation at the lens insertion site
Stop using the product and contact your doctor or eye care professional right away if you develop eye pain, changes in vision, increasing redness, or itching that doesn't improve or lasts beyond 72 hours — these may signal a more serious problem.
⚠️Warnings & precautions▾
- Corneal ulcers and eye infections: Do not insert ACUVUE Theravision lenses if you have a corneal ulcer, corneal infection (bacterial, fungal, protozoal, or viral), dry eye disease, or any injury or abnormality of the eye or eyelids. Contact lens wear can worsen these conditions and threaten your sight.
- Red or irritated eyes: ACUVUE Theravision with Ketotifen should not be inserted into red or irritated eyes. Remove the lens immediately if your eye becomes red or irritated.
- Swimming and water exposure: Do not wear ACUVUE Theravision lenses while swimming or in hot tubs. Never rinse them with tap water. These actions raise the risk of serious eye infections.
- Chemical splashes: If any chemical gets in your eyes, flush immediately with water and get emergency care right away — do not delay.
- Smokers: Contact lens wearers who smoke have a higher rate of corneal ulcers than non-smokers.
- Eye drops: Do not use ketotifen eye drops to treat contact lens-related irritation. Always remove lenses before applying drops and wait at least 10 minutes before reinserting them.
🔀What it interacts with▾
There are limited drug interactions with ketotifen eye products, but one important one to know about:
- Benzalkonium chloride-containing eye drops or medications: These should not be used at the same time as ACUVUE Theravision with Ketotifen lenses. If you need to use such a product, apply the drops first and wait at least 10 minutes before inserting the lens — benzalkonium chloride can damage the lens.
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not use ketotifen eye drops if you are allergic to any ingredient in the product, or if the solution has changed color or turned cloudy.
- Do not use the eye drops to treat irritation caused by contact lenses.
- ACUVUE Theravision with Ketotifen is contraindicated in patients with red or irritated eyes (ocular hyperemia), decreased corneal sensation (corneal hypoesthesia), or any active corneal infection.
- The safety and effectiveness of ACUVUE Theravision with Ketotifen have not been established in children under 11 years of age.
- Children under 3 years of age should not use ketotifen eye drops without consulting a doctor.
- There is limited data on use of ACUVUE Theravision with Ketotifen in adults 65 and older.
- If you are pregnant: ACUVUE Theravision with Ketotifen is not expected to be absorbed into the body in meaningful amounts through the eye, so fetal exposure is unlikely — but no adequate human studies exist. Talk to your doctor.
- If you are breastfeeding: It is not known whether ketotifen from eye use passes into breast milk in detectable amounts. Discuss the benefits and risks with your doctor.
📡Pharmacodynamics — effects in the body▾
Ketotifen blocks H1 histamine receptors in the eye and stabilizes mast cells, preventing the release of histamine and other allergy-triggering chemicals. It also inhibits the buildup of eosinophils — immune cells involved in allergic reactions — in eye tissue. In clinical studies of the ACUVUE Theravision contact lens, this itch-preventing effect was demonstrated to last through 12 hours of lens wear.
📦How to store it▾
Store at 20° to 25°C (68° TO 77°F) .
📄 Written from Ketotifen’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Ketotifen — the kind of thing our pharmacy team would talk through with you at the counter.
What exactly does ketotifen do for my eyes? ▾
How often do I use the eye drops, and can I use them with contacts in? ▾
What's different about the ACUVUE Theravision contact lens compared to the eye drops? ▾
When should I stop using ketotifen and call a doctor? ▾
Can I use ketotifen eye drops if I'm pregnant or breastfeeding? ▾
Can children use ketotifen eye drops? ▾
Is Ketotifen available over the counter? ▾
When was Ketotifen first available? ▾
Who makes Ketotifen? ▾
💬 Answers drafted from Ketotifen’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Ketotifen comes
Ketotifen is available in 1 form. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Eye drops
How this form is used
- Alaway, Allergy Eye Drops, Equate Eye Itch Relief, and Eye Itch eye drops temporarily relieve itchy eyes due to pollen, ragweed, grass, animal hair, and dander
- ACUVUE Theravision with Ketotifen is a drug-eluting daily contact lens used to prevent eye itch due to allergic conjunctivitis and to correct nearsightedness or farsightedness
- Alaway, Allergy Eye Drops, Equate Eye Itch Relief, and Eye Itch drops: adults and children 3 years and older apply 1 drop in the affected eye(s) twice daily, every 8 to 12 hours, no more than twice per day; children under 3 should consult a doctor
- If using other eye products with Alaway, Allergy Eye Drops, Equate Eye Itch Relief, or Eye Itch drops, wait at least 5 minutes between each product
- ACUVUE Theravision with Ketotifen: insert one lens per eye per day; remove before sleeping and discard after a single day's use
- ACUVUE Theravision with Ketotifen: do not use eye drops or medications containing benzalkonium chloride at the same time — wait at least 10 minutes after any eye drop application before inserting the lens
📊 Ketotifen across the U.S. market
How Ketotifen appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (9) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Ketotifen is used
A general measure of how commonly Ketotifen is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Ketotifen is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Ketotifen prescribed? Of the 1,596 medications we measure, Ketotifen ranks #216 by Medicaid prescriptions — more than 86% of them.
Utilization by Ketotifen product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
ketotifen 0.25 MG/ML Ophthalmic Solution
Summed across the 9 of 60 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 311237
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Ketotifen, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 9 of 60 listed Ketotifen NDCs with Medicaid activity.
🔍 Compare Ketotifen products
A representative set of FDA-listed product records for Ketotifen — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Eye drops | ||||
| 0.25 mg/mL | Ophthalmic | A-S Medication Solutions | NDA | View NDC → |
| 0.25 mg/mL | Ophthalmic | A-S Medication Solutions | NDA AUTHORIZED GENERIC | View NDC → |
| 0.35 mg/mL | Ophthalmic | A-S Medication Solutions × 2 listings | ANDA | View NDC → |
| 0.35 mg/mL | Ophthalmic | Akorn | ANDA | View NDC → |
| 0.25 mg/mL | Ophthalmic | Alcon Laboratories, Inc. × 2 listings | ANDA | View NDC → |
| 0.25 mg/mL | Ophthalmic | Armas Pharmaceuticals Inc. | ANDA | View NDC → |
| 0.25 mg/mL | Ophthalmic | Bausch & Lomb Incorporated | NDA | View NDC → |
| 0.35 mg/mL | Ophthalmic | Bausch & Lomb Incorporated | ANDA | View NDC → |
| 0.25 mg/mL | Ophthalmic | Bayshore Pharmaceuticals, LLC | ANDA | View NDC → |
| 0.25 mg/mL | Ophthalmic | Cardinal Health × 2 listings | NDA | View NDC → |
| 0.35 mg/mL | Ophthalmic | Cardinal Health | ANDA | View NDC → |
| 0.35 mg/mL | Ophthalmic | Cardinal Health 110, Llc. Dba Leader | ANDA | View NDC → |
| 0.25 mg/mL | Ophthalmic | CVS Pharmacy × 3 listings | NDA | View NDC → |
| 0.35 mg/mL | Ophthalmic | CVS Pharmacy × 5 listings | ANDA | View NDC → |
| 0.25 mg/mL | Ophthalmic | Direct Rx | ANDA | View NDC → |
| 0.35 mg/mL | Ophthalmic | Direct Rx | ANDA | View NDC → |
| 0.35 mg/mL | Ophthalmic | H E B × 2 listings | ANDA | View NDC → |
| 0.019 mg | Intraocular | Johnson & Johnson Vision Care, Inc. | NDA | View NDC → |
| 0.25 mg/mL | Ophthalmic | Kroger Company × 2 listings | NDA | View NDC → |
| 0.35 mg/mL | Ophthalmic | Kroger Company | ANDA | View NDC → |
| 0.35 mg/mL | Ophthalmic | Meijer Distribution Inc × 2 listings | ANDA | View NDC → |
| 0.25 mg/mL | Ophthalmic | Perrigo Direct Inc. | NDA | View NDC → |
| 0.25 mg/mL | Ophthalmic | Preferred Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 0.35 mg/mL | Ophthalmic | Proficient Rx LP | ANDA | View NDC → |
| 0.25 mg/mL | Ophthalmic | Redpharm Drug | NDA | View NDC → |
| 0.35 mg/mL | Ophthalmic | Remedyrepack Inc. | ANDA | View NDC → |
| 0.25 mg/mL | Ophthalmic | Rite Aid Corporation × 2 listings | NDA | View NDC → |
| 0.35 mg/mL | Ophthalmic | Rite Aid Corporation × 2 listings | ANDA | View NDC → |
| 0.25 mg/mL | Ophthalmic | Rugby Laboratories × 3 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 0.35 mg/mL | Ophthalmic | Rugby Laboratories | ANDA | View NDC → |
| 0.25 mg/mL | Ophthalmic | Safeway × 2 listings | NDA | View NDC → |
| 0.25 mg/mL | Ophthalmic | Sentiss Pharmaceuticals LLC | ANDA | View NDC → |
| 0.35 mg/mL | Ophthalmic | Strategic Sourcing Services Llc × 2 listings | ANDA | View NDC → |
| 0.25 mg/mL | Ophthalmic | Target Corporation × 3 listings | NDA | View NDC → |
| 0.25 mg/mL | Ophthalmic | Topco Associates Llc × 2 listings | NDA | View NDC → |
| 0.25 mg/mL | Ophthalmic | Unichem Pharmaceuticals (USA), Inc. | ANDA | View NDC → |
| 0.25 mg/mL | Ophthalmic | Wal-Mart Stores, Inc. | NDA | View NDC → |
| 0.35 mg/mL | Ophthalmic | Walgreen Company × 2 listings | NDA | View NDC → |
| 0.25 mg/mL | Ophthalmic | Walgreens | ANDA | View NDC → |
| 💊Bulk drug substance | ||||
| 25 g/25 g | — | Darmerica, Llc | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Kalintis Healthcare Private Limited | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Letco Medical, Llc | BULK INGREDIENT | View NDC → |
| 1 g/g | — | MEDISCA Inc. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Olon SpA | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Professional Compounding Centers of America | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 g/g | — | Spectrum Laboratory Products, Inc. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Zhejiang Huahai Pharmaceutical Co., Ltd. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Zhejiang Supor Pharmaceuticals Co., Ltd | BULK INGREDIENT | View NDC → |
Showing 71 of 71 products — FDA National Drug Code Directory. See every product, package size and price: browse all 71 Ketotifen NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Ketotifen — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Ketotifen in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Ketotifen went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 6146 4 dose forms · 4 strengths
-
Dose form (SCDF) Ophthalmic Solution RxCUI 372550In current FDA listingsClinical drug / strength (SCD) 0.25 MG/MLRxCUI 311237 -
Dose form (SCDF) Oral Capsule RxCUI 372548No current FDA listingClinical drug / strength (SCD) 1 MGRxCUI 250435 -
Dose form (SCDF) Oral Solution RxCUI 372549No current FDA listingClinical drug / strength (SCD) 0.2 MG/MLRxCUI 246129 -
Dose form (SCDF) Oral Tablet RxCUI 372552No current FDA listingClinical drug / strength (SCD) 1 MGRxCUI 246127
Look up RxCUI 6146 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Ketotifen is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 15 more on the FDA NDC directory.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 38 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Walgreen Company is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.